News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard May 13, 2022 StatementCOVID-19 Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan Download May 6, 2022 StatementCOVID-19 Novavax Submits Variations to Expand Australian and New Zealand Provisional Approval of Nuvaxovid™ COVID-19 Vaccine to Adolescents aged 12 Through 17 Years Download May 6, 2022 StatementCOVID-19 Novavax’ COVID-19 Vaccine Nuvaxovid™ Arrives in Singapore Download Apr 29, 2022 COVID-19 FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine Download Apr 22, 2022 COVID-19 Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial Download Apr 20, 2022 COVID-19 Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Download Apr 19, 2022 COVID-19 Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan Download Apr 18, 2022 COVID-19 Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases Download Apr 13, 2022 COVID-19 Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Apr 8, 2022 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand Download Mar 31, 2022 COVID-19 Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) Download Mar 25, 2022 COVID-19 Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine Download Mar 22, 2022 COVID-19 Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India Download Feb 28, 2022 COVID-19 Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial Download Feb 23, 2022 COVID-19 Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States Download Feb 17, 2022 COVID-19 Health Canada Authorizes Novavax COVID-19 Vaccine Download Feb 14, 2022 Press releaseCOVID-19 Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine Download Feb 14, 2022 COVID-19 Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland Download Feb 10, 2022 COVID-19 Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial Download Feb 3, 2022 COVID-19 New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine Download Feb 3, 2022 COVID-19 Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* Download Jan 31, 2022 COVID-19 Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine Download Jan 28, 2022 COVID-19 Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine Download Jan 19, 2022 COVID-19 Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine Download Jan 12, 2022 COVID-19 South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine Download Jan 10, 2022 COVID-19 Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa Download Dec 31, 2021 COVID-19 Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine Download Dec 28, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India Download Dec 23, 2021 COVID-19 Novavax and SK bioscience Expand Manufacturing Agreement Download Dec 22, 2021 COVID-19 Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies Download Dec 21, 2021 COVID-19 Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study Download Dec 20, 2021 COVID-19 World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine Download Dec 17, 2021 COVID-19 Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine Download Dec 15, 2021 COVID-19 Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine Download Dec 15, 2021 StatementCOVID-19 Novavax Statement on PREVENT-19 Phase 3 Clinical Trial Results Publication in the New England Journal of Medicine Download Dec 13, 2021 COVID-19 Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates Download Dec 2, 2021 StatementCOVID-19 Novavax Statement on Omicron Variant Response Download Nov 24, 2021 Corporate and financeCOVID-19 Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore Download Nov 18, 2021 StatementCOVID-19 Novavax Statement on Publication of Positive Results from First Study of Co-administered COVID-19 and Influenza Vaccines Download Nov 17, 2021 COVID-19 Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization Download Nov 17, 2021 Corporate and financeCOVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines Download Nov 10, 2021 StatementCOVID-19 Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully Vaccinated in the US Download Nov 4, 2021 Corporate and financeCOVID-19 Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization Download Nov 3, 2021 COVID-19 Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand Download Nov 1, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia Download Nov 1, 2021 Corporate and financeCOVID-19 Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency Download Oct 29, 2021 Corporate and financeCOVID-19 Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia Download Oct 27, 2021 Corporate and financeCOVID-19 Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom Download Oct 20, 2021 StatementCOVID-19 Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality Download Oct 19, 2021 StatementCOVID-19 Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World Vaccine Congress Europe Download Oct 15, 2021 COVID-19Seasonal influenza Novavax to Participate in World Vaccine Congress Europe Download Oct 11, 2021 StatementCOVID-19 Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vaccine Posted to medRxiv Download Sep 29, 2021 COVID-19 Novavax to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sciences Bio Innovation Conference Download Sep 24, 2021 COVID-19 Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County Download Sep 23, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine Download Sep 20, 2021 COVID-19 Novavax to Participate in Fireside Chat at Devex @ UNGA 76 Download Sep 17, 2021 StatementCOVID-19 Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S. Download Sep 16, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents Download Sep 10, 2021 StatementCOVID-19 Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan Download Sep 8, 2021 COVID-19 Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza Download Aug 30, 2021 COVID-19 Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants Download Aug 25, 2021 COVID-19 Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems Download Aug 5, 2021 COVID-19 Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination Download Aug 5, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine Download Aug 4, 2021 COVID-19 Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine Download Jun 30, 2021 COVID-19 Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine Download Jun 30, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants: Updated June 30, 2021 Download Jun 22, 2021 StatementCOVID-19 Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre Download Jun 14, 2021 COVID-19Seasonal influenza Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously Download Jun 14, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Download Jun 11, 2021 COVID-19 Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine Download Jun 7, 2021 COVID-19 Novavax to Participate in Panel at BIO Digital 2021 Download May 27, 2021 COVID-19 Novavax to Participate in Jefferies Virtual Healthcare Conference Download May 24, 2021 COVID-19 Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update Download May 22, 2021 COVID-19 Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea Download May 22, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants in the United Kingdom Download May 21, 2021 StatementCOVID-19 Complete Trial Results Manuscript of Novavax COVID-19 Investigational Vaccine Posted to Preprint Server medRxiv Download May 21, 2021 StatementCOVID-19 Novavax Statement on Participation in Mix-and-Match COVID-19 Vaccine Booster Trial in the United Kingdom Download May 10, 2021 StatementCOVID-19 Novavax Statement on Updated PREVENT-19 Trial Protocol Download May 10, 2021 COVID-19Seasonal influenza Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate Download May 7, 2021 StatementCOVID-19 Novavax Statement on Ministry of Health, Labour and Welfare’s Announcement Regarding Procurement from Takeda of NVX-CoV2373 for Japan Download May 7, 2021 StatementCOVID-19 Novavax Statement in Opposition to the WTO TRIPS Waiver Download May 6, 2021 COVID-19 Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility Download Apr 14, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations Download Apr 5, 2021 COVID-19 Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover Download Mar 29, 2021 COVID-19 GSK to support manufacture of Novavax' COVID-19 vaccine Download Mar 11, 2021 COVID-19 Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Download Feb 26, 2021 COVID-19 Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan Download Feb 22, 2021 COVID-19 Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico Download Feb 18, 2021 COVID-19 Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine Download Feb 15, 2021 COVID-19 Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea Download Feb 4, 2021 COVID-19 Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization Download Feb 3, 2021 COVID-19 Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine Download Feb 2, 2021 COVID-19 Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada Download Feb 1, 2021 COVID-19 Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science Download Jan 28, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial Download Jan 22, 2021 COVID-19 Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine Download Jan 7, 2021 COVID-19 Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine Download Show 5102550100 per page«12»